PEX5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.70500000018903E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.14670000050943E-07 |
Normal-vs-Stage2 |
3.84709999999844E-05 |
Normal-vs-Stage3 |
6.25209999999266E-05 |
Normal-vs-Stage4 |
1.436030E-02 |
Stage1-vs-Stage2 |
6.595000E-01 |
Stage1-vs-Stage3 |
4.944600E-01 |
Stage1-vs-Stage4 |
6.441400E-01 |
Stage2-vs-Stage3 |
3.395000E-01 |
Stage2-vs-Stage4 |
4.854000E-01 |
Stage3-vs-Stage4 |
9.212600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.43020000001426E-06 |
Normal-vs-AfricanAmerican |
2.38259999999491E-05 |
Normal-vs-Asian |
7.541000E-03 |
Caucasian-vs-AfricanAmerican |
9.085000E-01 |
Caucasian-vs-Asian |
5.419200E-01 |
AfricanAmerican-vs-Asian |
5.592000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.51149999686007E-08 |
Normal-vs-Female |
2.215000E-03 |
Male-vs-Female |
1.001410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.41019999999148E-05 |
Normal-vs-Extreme_Weight |
1.0730999977504E-08 |
Normal-vs-Obese |
5.6752999999965E-05 |
Normal-vs-Extreme_Obese |
1.135780E-03 |
Normal_Weight-vs-Extreme_Weight |
4.018800E-01 |
Normal_Weight-vs-Obese |
4.357000E-01 |
Normal_Weight-vs-Extreme_Obese |
8.124200E-01 |
Extreme_Weight-vs-Obese |
5.730100E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.120000E-01 |
Obese-vs-Extreme_Obese |
4.573400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.590300E-02 |
Normal-vs-Age(41-60Yrs) |
4.44150000000754E-05 |
Normal-vs-Age(61-80Yrs) |
3.73690000055049E-08 |
Normal-vs-Age(81-100Yrs) |
2.937700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.817400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.513500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.889400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.207700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.327200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.394600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.08450000002591E-06 |
Normal-VS-Type2 PRCC |
1.757130E-04 |
Normal-VS-KIRP CIMP |
8.978100E-04 |
Normal-VS-Unclassified PRCC |
1.739630E-03 |
Type1 PRCC-VS-Type2 PRCC |
9.153200E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.664600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.225200E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.926600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
7.307800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.675800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.0770999999975E-06 |
Normal-vs-N1 |
1.684140E-02 |
Normal-vs-N2 |
6.249200E-01 |
N0-vs-N1 |
1.858250E-01 |
N0-vs-N2 |
6.569800E-01 |
N1-vs-N2 |
8.279400E-01 |
|
|